Article
Quadruple mutation GCAC1809-1812TTCT acts as a biomarker in healthy European HBV carriers.
JCI insight - 19 Nov 2020
Peiffer Kai-Henrik, Spengler Catrina, Basic Michael, Jiang Bingfu, Kuhnhenn Lisa, Obermann Wiebke, Zahn Tobias, Glitscher Mirco, Loglio Alessandro, Facchetti Floriana, Carra Gert, Kubesch Alica, Vermehren Johannes, Knop Viola, Graf Christiana, Dietz Julia, Finkelmeier Fabian, Herrmann Eva, Trebicka Jonel, Grünweller Arnold, Zeuzem Stefan, Sarrazin Christoph, Lampertico Pietro, Hildt Eberhard
Abstract excerpt
Many mutation analyses of the HBV genome have been performed in the search for new prognostic markers. However, the Kozak sequence preceding precore was covered only infrequently in these analyses. In this study, the HBV core promoter/precore region was sequenced in serum samples from European inactive HBV carriers. Quadruple mutation GCAC1809-1812TTCT was found with a high prevalence of 42% in the Kozak sequence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
